Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 105.09

-0.6%

9:36 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (3046)	10/29/2014 12:44:20 PM
From: scaram(o)uche	Read Replies (1) of 3202

updated..... GILD - Idelalisib, GS-9901 (GS-9901 not confirmed PI3Kdelta, but likely) INCY - INCB40093 and INCB050465 TGTX - TGR-1202 (Rhizen license) INFI - IPI-145 and IPI-443 (delta/gamma, IPI-145 licensed to AbbVie, $275M upfront, INFI retains rights to IPI-443) Rhizen - RP6530 (delta/gamma) (GILD and INCY continue to head bash.) More? Pharma projects that will make me look silly when we see their advanced status??

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next